The historic rise of Viagra has firmly established as a example of pharmaceutical success, but its legacy within the broader industry now raises questions about future returns . Alternative versions are eroding exclusivity , causing worries that betting on companies significantly dependent to Viagra's once-dominant influence could be a problematic